Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
Cutaneous side effects of anti–tumor necrosis factor biologic therapy: A clinical review
Journal of the American Academy of Dermatology, 08/25/09
Moustou AE et al. – As anti–TNF biologic agents are progressively being used in clinical practice, cutaneous adverse events will be encountered more frequently. Until more data are accumulated with respect to their pathogenesis and potential association with anti–TNF therapy, dermatologists should become more familiar with the clinical presentation and management of such events.
Related Articles
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor [alpha] therapies: Does the risk change with the time since start of treatment?
Arthritis & Rheumatism, 11/05/09
Relevance Score: 80%
Erythrocyte sedimentation rate, CRP level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis
Arthritis Care and Research, 11/02/09
Relevance Score: 80%
Anti-tumor Necrosis Factor Treatment Does Not Increase Cancer Risk In Rheumatoid Arthritis Patients, Study Finds
ScienceDaily, 10/30/09
Relevance Score: 80%
Cutaneous vasculitis induced by TNF inhibitors: a report of three cases
Modern Rheumatology, 10/16/09
Relevance Score: 79%
Effective anti-tnf-î± therapy can induce rapid resolution and sustained decrease of gastroduodenal mucosal amyloid deposits in reactive amyloidosis associated with rheumatoid arthritis
Journal of Rheumatology, 10/09/09
Relevance Score: 78%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy, safety, and tolerability of microsphere adapalene vs. conventional adapalene for acne vulgaris
International Journal of Dermatology, 12/01/09
Depression in hospitalized patients with malignant melanoma treated with interferon-alpha-2b: primary to induced disorders
European Journal of Dermatology, 12/01/09
Vitiligo therapy
Expert Opinion in Pharmacotherapy, 12/01/09
Sponsor
Article Search
Sponsor


See Latest Articles


